MARLBOROUGH, Mass.--(BUSINESS WIRE)--Xcellerex, Inc., which provides next generation manufacturing services and systems for biotherapeutics and vaccines based on proprietary, single use, disposable component technology, announced today the appointment of John Chickosky to the newly created position of Chief Operating Officer. Mr. Chickosky joins Xcellerex with more than 20 years of senior management experience in life science technology companies including Kendro Laboratory Products, CARR Separations, and Sepracor.
